540729 — Vanta Bioscience Share Price
0.000.00%
Last trade - 00:00- IN₹131.04m
- IN₹744.74m
- IN₹97.23m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.96 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.86 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -9.29% | ||
| Return on Equity | -25.15% | ||
| Operating Margin | -126.16% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 141.43 | 100.38 | 96.87 | 62.76 | 97.23 | n/a | n/a | -4.79% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +3.21 | -56.88 | -79.64 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Vanta Bioscience Limited is an India-based preclinical contract research company. The Company provides services for testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research, and environmental studies. It offers a host of preclinical safety assessment services for clients from pharmaceuticals, medical devices, nutraceuticals, feed additives, biotech, agrochemicals, cosmetics, and chemical industries. Additionally, it provides risk assessment services to evaluate the safety of active pharmaceutical ingredients, excipients, extractables, leachable, and pharmaceutical impurities resulting from the manufacturing process or product degradation. The Company’s services include discovery toxicology, agro-chemical and chemical safety, biocompatibility studies, diet formulation, and batch release tests. The Company has investments in one of its subsidiaries, Vantaclinical Research Limited.
Directors
- Mohan Mulakala NEC (63)
- Sadhanala Rao CEO
- Annabatula Kumar CFO
- Zoheb Sayani CCO
- Dopesh Mulakala MDR (37)
- Vyasmurti Shingatgeri EDR (62)
- Padmanabhuni Appaji IND
- Yogeswara Danda IND
- Kathyayani Gonuguntla IND
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- April 29th, 2016
- Public Since
- October 6th, 2017
- No. of Employees
- 48
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 6,312,000
- Address
- No.02/G/308/G,, No.3/Ff/Sf/1-20-248, SECUNDERABAD, 500003
- Web
- https://www.vantabio.com/
- Phone
- +91 4066575454
- Auditors
- M/s. Mathesh & Ramana.
Upcoming Events for 540729
Vanta Bioscience Ltd Annual Shareholders Meeting
Similar to 540729
Indo US Bio-Tech
Bombay Stock Exchange
Jeevan Scientific Technology
Bombay Stock Exchange
Shree Ganesh Remedies
Bombay Stock Exchange
Transgene Biotek
Bombay Stock Exchange
Vivo Bio Tech
Bombay Stock Exchange
FAQ
What is the Vanta Bioscience share price?
As of Today at 23:56 UTC, shares in Vanta Bioscience are trading at IN₹20.76. This share price information is delayed by 15 minutes.
How has the Vanta Bioscience share price performed this year?
Shares in Vanta Bioscience last closed at IN₹20.76 and the price had moved by -66.25% over the past 365 days. In terms of relative price strength the Vanta Bioscience share price has underperformed the S&P BSE 100 Index by -68.21% over the past year.
What are the analyst and broker recommendations for Vanta Bioscience?
There is no consensus recommendation for this security.
Find out moreWhat is the Vanta Bioscience dividend yield?
Vanta Bioscience does not currently pay a dividend.
Does Vanta Bioscience pay a dividend?
Vanta Bioscience does not currently pay a dividend.
When does Vanta Bioscience next pay dividends?
Vanta Bioscience does not currently pay a dividend.
How do I buy Vanta Bioscience shares?
To buy shares in Vanta Bioscience you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Vanta Bioscience?
As of the previous close price of IN₹20.76, shares in Vanta Bioscience had a market capitalisation of IN₹131.04m.
Where are Vanta Bioscience shares listed?
Here are the trading details for Vanta Bioscience:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 540729
What kind of share is Vanta Bioscience?
Based on an overall assessment of its quality, value and momentum Vanta Bioscience is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Vanta Bioscience share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Vanta Bioscience share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vanta Bioscience. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -48.92%.
As of the last closing price of IN₹20.76, shares in Vanta Bioscience were trading -57.6% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Vanta Bioscience PE Ratio?
The Vanta Bioscience PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹20.76.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Vanta Bioscience?
Vanta Bioscience's management team is headed by:
- Mohan Mulakala - NEC
- Sadhanala Rao - CEO
- Annabatula Kumar - CFO
- Zoheb Sayani - CCO
- Dopesh Mulakala - MDR
- Vyasmurti Shingatgeri - EDR
- Padmanabhuni Appaji - IND
- Yogeswara Danda - IND
- Kathyayani Gonuguntla - IND